Skip to main content
SpringerLink
Log in

Vulvakarzinom

Diagnostik und Therapie

Vulvar cancer

Diagnosis and treatment

  • CME Weiterbildung • Zertifizierte Fortbildung
  • Published:
Der Gynäkologe Aims and scope

Zusammenfassung

Das Vulvakarzinom ist ein seltener Genitaltumor der Frau. Der Häufigkeitsgipfel liegt im Alter zwischen 70 und 79 Jahren mit einer langsamen Tendenz zur altersmäßigen Vorverlagerung. In über 90% handelt es sich um ein Plattenepithelkarzinom. Die zugehörige intraepitheliale Präneoplasie VIN tritt am häufigsten bei Frauen unter 35 Jahren auf. Heute geht man davon aus, dass 2 Typen unterschieden werden können: eine durch das humane Papillomavirus (HPV) induzierte, eher bei jüngeren Frauen auftretende Neoplasie und eine HPV-unabhängige Neoplasie eher im höheren Alter. Bereits die VIN sollte chirurgisch entfernt werden. Die invasiven Karzinome können im Stadium I und II durch eine lokale weite Exzision im Gesunden reseziert werden, die inguinofemoralen Lymphknoten werden ab einer Eindringtiefe von 1,1 mm reseziert. Bei größeren Tumoren wird eine Vulvektomie mit beidseitiger Lymphonodektomie erforderlich. Bei weit fortgeschrittenen Tumoren kommen multimodale Therapieplanungen zum Einsatz, dabei kann eine primäre Radiochemotherapie einer Salvage-Operation vorangestellt werden.

Abstract

Vulvar cancer is a rare entity. It appears mostly in older women aged 70–79 years with a slow tendency toward younger age. More than 90% of the tumors show a squamous differentiation. The correspondent preneoplasia is VIN. This lesion occurs in women mostly younger than 35 years. Experts assume that vulvar cancer appears in two different types: HPV-induced type in younger women and non-HPV-dependent type in older women. The preneoplasia VIN already should be treated by resection or destruction. Invasive carcinomas stage I or II can be treated by wide local excision. The inguinofemoral lymph nodes should be resected if invasion exceeds 1 mm in depth. In larger primary tumors, vulvectomy with bilateral inguinofemoral node dissection is indicated. In advanced tumor stages, multimodal concepts are applied: primary radiochemotherapy may precede a salvage operation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Ambros RA, Malfetano JH, Mihm MC Jr (1996) Clinicopathologic features of vulvar squamous cell carcinomas exhibiting prominent fibromyxoid stromal response. Int J Gynecol Pathol 15: 137–145

    PubMed  CAS  Google Scholar 

  2. Bancher-Todesca D, Obermair A, Bilgi S et al. (1997) Angiogenesis in vulvar intraepithelial neoplasia. Gynecol Oncol 64: 496–500

    Article  PubMed  CAS  Google Scholar 

  3. Barnes EA, Thomas G (2006) Integrating radiation into the management of vulvar cancer. Semin Radiat Oncol 16: 168–176

    Article  PubMed  Google Scholar 

  4. Bellati F, Angioli R, Manci N et al. (2005) Single agent cisplatin chemotherapy in surgically resected vulvar cancer patients with multiple inguinal lymph node metastases. Gynecol Oncol 96: 227–231

    Article  PubMed  CAS  Google Scholar 

  5. Beller U, Sideri M, Maisonneuve P et al. (2001) Carcinom of the Vulva. ANNUAL REPORT on the Results of Treatment in Gynaecological Cancer. J Epidemiol Biostat 6: 153–174

    Google Scholar 

  6. BenDavid Y, Lickrish GM, Rosen BP et al. (1996) Vulvar intra-epithelial neoplasia-treatment outcome. Int J Gynecol Cancer 6: 145–148

    Article  Google Scholar 

  7. Bender HG (1991) Tumoren der Vulva. In: Bender HG (Hrsg) Gynäkologische Onkologie. 2. Aufl. Thieme, Stuttgart New York, S 335‑346

  8. Benedetti-Panici P, Greggi S, Scambia G et al. (1993) Cisplatn (P), bleomycin (B), and methotrexate (M) preoperative chemotherapy in locally advanced vulvar carcinoma. Gynecol Oncol 50: 49–53

    Article  PubMed  CAS  Google Scholar 

  9. Boronow RC, Hickman BT, Reagan MT (1987) Combined therapy as an alternative to exenteration for locally advanced vulvovaginal cancer. II. Results, complications, and dosimetric and surgical considerations. Am J Clin Oncol 10(2): 171–181

    Article  PubMed  CAS  Google Scholar 

  10. Burger MPM, Hollema H, Bouma J (1996) The side of groin node metastases in unilateral vulvar carcinoma. Int J Gynecol Cancer 6: 318–322

    Article  Google Scholar 

  11. Cavanagh D (1997) Vulvar cancer – continuing evolution in management. Gynecol Oncol 66: 362–367

    Article  PubMed  CAS  Google Scholar 

  12. Collins CG, Hansen LH, Theriot E (1966) A clinical stain for use in selecting biopsy sites in patients with vulvar diseases. Obstet Gynecol 28: 158

    PubMed  CAS  Google Scholar 

  13. Copeland LJ, Sneige N, Gershenson DM (1986) Bartholin carcinoma. Obstet Gynecol 67: 794–801

    Article  PubMed  CAS  Google Scholar 

  14. Cunningham MJ, Goyer RP, Gibbons SK et al. (1997) Primary radiation, cisplatin, and 5-fluorouracil for advanced squamous carcinoma of the vulva. Gynecol Oncol 66: 258–261

    Article  PubMed  CAS  Google Scholar 

  15. De Hullu JA, Hollema H, Piers DA et al. (2000) Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol 18: 2811–2816

    Google Scholar 

  16. Deppe G, Bruckner HW, Cohen CJ (1977) Adriamycin treatment of vulvar carcinoma. Obstet Gynecol (Suppl 1) 50: 13s–14s

    Google Scholar 

  17. DePasquale SE, McGuinness TB, Mangan CE et al. (1996) Adenoid cystic carcinoma of Bartholin’s gland: a review of the literature and report of a patient. Gynecol Oncol 61: 122–125

    Article  PubMed  CAS  Google Scholar 

  18. Durrant KR, Mangioni C, Lacave AJ et al. (1990) Bleomycin, methotrexate, and CCNU in advanced inoperable squamous cell carcinoma of the vulva: a phase II study of the EORTC Gynaecological Cancer Cooperative Group (GCCG). Gynecol Oncol 37: 359–362

    Article  PubMed  CAS  Google Scholar 

  19. Feakins RM, Lowe DG (1997) Basal cell carcinoma of the vulva. A clinicopathologic study of 45 cases. Int J Gynecol Pathol 16: 319–324

    PubMed  CAS  Google Scholar 

  20. Flam F, Larson B (1997) Adenoid cystic carcinoma of Bartholin’s gland: a review of the literature and report of a patient with widespread metastases to the bone. Int J Gynecol Cancer 7: 458–460

    Article  Google Scholar 

  21. Gerszten K, Selvaraj RN, Kelley J, Faul C (2005) Preoperative chemoradiation for locally advanced carcinoma of the vulva. Gynecol Oncol 99: 640–644

    Article  PubMed  Google Scholar 

  22. Gordinier ME, Steinhoff MM, Hogan JW et al. (1997) S-phase fraction, p53, and HER-2/neu status as predictors of nodal metastasis in early vulvar cancer. Gynecol Oncol 67: 200–202

    Article  PubMed  CAS  Google Scholar 

  23. Hacker NF (2005) Vulvar cancer. In: Berek J, Hacker N (eds) Practical gynecologic oncology, 3rd edn. Williams & Wilkins, Baltimore, pp 543–583

  24. Hacker NF, Berek JS (1990) Vulva. In: Haskell CM (ed) Cancer treatment, 3rd edn. Saunders, Philadelphia, pp 351–361

  25. Heaps JM, Fu YS, Montz FJ (1990) Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol 38: 309

    Article  PubMed  CAS  Google Scholar 

  26. Helm CW (2000) Rare tumors of the vulva. In: Luesley DM (ed) Cancer and precancer of the vulva. Arnold, London, pp 151–175

  27. Helm CW, Hatch K, Austin JM (1992) A matched comparison of single and triple incision techniques for the surgical treatment of carcinoma of the vulva. Gynecol Oncol 46: 150–156

    Article  PubMed  CAS  Google Scholar 

  28. Hillemanns HG, Schillinger H, Hilgarth M, Schmidt-Matthiesen H (1991) Präneoplasien und Neoplasien der Vulva. In: Schmidt-Matthiesen H (Hrsg) Klinik der Frauenheilkunde und Geburtshilfe, Bd. 11, 3. Aufl. Urban & Schwarzenberg, München, S 49–104

  29. Homesley HD, Bundi BN, Sedlis A, Adcock L (1986) Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol 68: 733

    PubMed  CAS  Google Scholar 

  30. Homesley HD, Bundi BN, Sedlis A et al. (1991) Assessment of current international federation of gynecology and obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a GOG Group study). Am J Obstet Gynecol 164: 997–1004

    PubMed  CAS  Google Scholar 

  31. Hording U, Daugaard S, Junge J, Lundvall F (1996) Human papillomaviruses and multifocal genital neoplasia. Int J Gynecol Pathol 15: 230–234

    PubMed  CAS  Google Scholar 

  32. Ikenberg H, Schwörer D, Pfleiderer A (1988) Nachweis von humaner Papilloma-Virus(HPV)-DNA in Vulvakarzinomen. Geburtsh Frauenheilkd 48: 776–779

    Article  CAS  Google Scholar 

  33. Johnson GA, Mannell R, Khalifa M et al. (1997) Epidermal growth factor receptor in vulvar malignancies and its relationship to metastasis and patient survival. Gynecol Oncol 65: 425–429

    Article  PubMed  CAS  Google Scholar 

  34. Judson PL, Habermann EB, Baxter NN et al. (2006) Trends in the incidence of invasive and in situ vulvar cancer. Am J Obstet Gynecol 107: 1018–1022

    Google Scholar 

  35. Kagie MJ, Kenter GG, Tollenaar RAEM et al. (1997) p53 protein overexpression, a frequent observation in squamous cell carcinoma of the vulva and in various synchronous vulvar epithelia, has no value as a prognostic parameter. Int J Gynecol Pathol 16: 124–130

    PubMed  CAS  Google Scholar 

  36. Kagie MJ, Kenter GG, Zomerdijk-Nooijen Y et al. (1997) Human papillomavirus infection in squamous cell carcinoma of the vulva, in various synchronous epithelial changes and in normal vulvar skin. Gynecol Oncol 67: 178–183

    Article  PubMed  CAS  Google Scholar 

  37. Knapstein PG, Friedberg V (1987) Plastische Operationen an der Vulva und Vagina. In: Knapstein PG, Friedberg V (Hrsg) Plastische Chirurgie in der Gynäkologie. Thieme, Stuttgart, S 73–128

  38. Kürzl R, Messerer D (1989) Prognostic factors in squamous cell carcinoma of the vulva: a multivariate analysis. Gynecol Oncol 32: 143–150

    Article  PubMed  Google Scholar 

  39. Landoni F, Maneo A, Zanetta G et al. (1996) Concurrent preoperative chemotherapy with 5-fluorouracil and mitomycin C and radiotherapy (FUMIR) followed by limited surgery in locally advanced and recurrent vulvar carcinoma. Gynecol Oncol 61: 321–327

    Article  PubMed  CAS  Google Scholar 

  40. Lawton FG (2000) Management of relapsed vulvar carcinoma. In: Luesley DM (ed) Cancer and precancer of the vulva. Arnold, London, pp 135–141

  41. Leiserowitz GS, Russell AH, Kinney WK et al. (1997) Prophylactic chemoradiation of inguinofemoral lymph nodes in patients with locally extensive vulvar cancer. Gynecol Oncol 66: 509–514

    Article  PubMed  CAS  Google Scholar 

  42. Leuchter RS, Hacker NF, Voet RL (1982) Primary carcinoma of the Bartholin gland. Obstet Gynecol 60: 361–368

    PubMed  CAS  Google Scholar 

  43. Levenback C, Morris M, Burke TW et al. (1996) Groin dissection practices among gynecologic oncologists treating early vulvar cancer. Gynecol Oncol 62: 73–77

    Article  PubMed  CAS  Google Scholar 

  44. Lucas WE (1981) Die stadienangepasste Therapie des Vulvakarzinoms. Gynäkologe 14: 150–158

    PubMed  CAS  Google Scholar 

  45. Manahan KJ, Hudec J, Fanning J (1997) Modified radical vulvectomy without lymphadenectomy under local anesthesia in medically compromised patients. Gynecol Oncol 67: 166–167

    Article  PubMed  CAS  Google Scholar 

  46. McConnell DT, WilsonBJ, Russell D et al. (1996) Rising incidence of vulval cancer in North East Scotland 1974–1994: a population based study. Int J Gynecol Cancer 6: 309–312

    Article  Google Scholar 

  47. Montana GS, Thomas GM, Moore DH et al. (2000) Preoperative chemoradiation for carcinoma of the vulva with N2/N3 nodes: a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 48: 1007–1013

    Article  PubMed  CAS  Google Scholar 

  48. Moore DH, Thomas GM, Montana GS et al. (1998) Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int J Radiat Oncol Biol Phys 42: 79–85

    Article  PubMed  CAS  Google Scholar 

  49. Obermair A, Kohlberger P, Bancher-Todesca D et al. (1996) Influence of microvessel density and vascular permeability factor/vascular endothelial growth factor expression on prognosis in vulvar cancer. Gynecol Oncol 63: 204–209

    Article  PubMed  CAS  Google Scholar 

  50. Paley PJ, Johnson PR, Adcock LL et al. (1997) The effect of Sartorius transposition on wound morbidity following inguinal-femoral lymphadenectomy. Gynecol Oncol 64: 237–241

    Article  PubMed  CAS  Google Scholar 

  51. Petry KU, Köchel H, Bode U et al. (1996) Human papillomavirus is associated with the frequent detection of warty and basaloid high-grade neoplasia among immunocompromised women. Gynecol Oncol 60: 30–34

    Article  PubMed  CAS  Google Scholar 

  52. Pfleiderer A (1986) Zytostatische Therapie des Vulvakarzinoms. In: Zander J, Baltzer J (Hrsg) Erkrankungen der Vulva. Urban & Schwarzenberg, München, S 174–184

  53. Robboy SJ, Bentley RC, Krigman H et al. (1994) Synoptic reports in gynecologic pathology. Int J Gynecol Pathol 13: 161–174

    PubMed  CAS  Google Scholar 

  54. Robert-Koch-Institut (RKI) und Gesellschaft der Epidemiologischen Krebsregister in Deutschland e.V. (GEKID) Krebs in Deutschland. RKI 2006

  55. Rodolakis A, Diakomanolis E, Vlachos G et al. (2003) Vulvar intraepithelial neoplasia (VIN) – diagnostic and therapeutic challenges. Eur J Gynaecol Oncol 24: 317–322

    PubMed  CAS  Google Scholar 

  56. Rodriguez M, Sevin BU, Averette HE et al. (1997) Conservative trends in the surgical management of vulvar cancer: a University of Miami patient care evaluation study. Int J Gynecol Cancer 7: 151–157

    Article  Google Scholar 

  57. Rosen C, Malmström H (1997) Invasive cancer of the vulva. Gynecol Oncol 65: 213–217

    Article  PubMed  CAS  Google Scholar 

  58. Sagerman PM, Choi YJ, Hu Y, Niedt GW (1996) Human papilloma virus, vulvar dystrophy, and vulvar carcinoma: differential expression of human papillomavirus and vulvar dystrophy in the presence and absence of squamous cell carcinoma of the vulva. Gynecol Oncol 61: 328–332

    Article  PubMed  CAS  Google Scholar 

  59. Scheistroen M, Tropé C, KaernJ et al. (1996) Malignant melanoma of the vulva FIGO stage I: evaluation of prognostic factors in 43 patients with emphasis on DNA ploidy and surgical treatment. Gynecol Oncol 61: 253–258

    Article  PubMed  CAS  Google Scholar 

  60. Schnürch H-G (1999) Vorsorgeuntersuchung der weiblichen Genitalorgane. In: Bender HG, Künzel W, Diedrich K (Hrsg) Spezielle gynäkologische Onkologie I. Klinik der Frauenheilkunde u. Geburtshilfe, Bd. 11, 4. Aufl. Urban & Schwarzenberg, München

  61. Schnürch H-G, Küppers V (1996) Therapie bei VIN 3 – standardisiert oder individuell? Zentralbl Gynakol 118: 345–349

    PubMed  Google Scholar 

  62. Schnürch H-G, Küppers V, Bender HG (1997) Vulva-Neoplasien. In: Zeller WJ, zur Hausen H (Hrsg) Onkologie – Grundlagen, Diagnostik, Therapie, Entwicklungen, Bd. 2 ecomed, Landsberg, 3. Ergänzungslieferung Mai; V-2.11, S 1–9

  63. Scurry J, Vanin K, Östör A (1997) Comparison of histological features of vulvar lichen sclerosis with and without adjacent squamous cell carcinoma. Int J Gynecol Cancer 7: 392–399

    Article  Google Scholar 

  64. Sideri M, Jones RW, Wilkonson EJ et al. (2005) Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD vulvar Subcommittee. J Reprod Med 50: 807–810

    PubMed  Google Scholar 

  65. Sun Y, Hildesheim A, Brinton LA et al. (1996) Human papillomavirus-specific serologic responses in vulvar neoplasia. Gynecol Oncol 63: 200–203

    Article  PubMed  CAS  Google Scholar 

  66. Tateo A, Tateo S, Bernasconi C, Zara C (1996) Use of V-Y flap for vulvar reconstruction. Gynecol Oncol 62: 203–207

    Article  PubMed  CAS  Google Scholar 

  67. Toki T, Kurman RJ, Park JS et al. (1991) Probable nonpaillomavirus etiology of squamous cell carcinoma of the vulva in older women: a clinicopathologic study using in situ hybridisation and polymerase chain reaction. Int J Gynecol Pathol 10: 107–125

    PubMed  CAS  Google Scholar 

  68. Trope C, Johnsson JE, Larsson G, Simonsen E (1980) Bleomycin alone or combined with mitomycin C in treatment of advanced or recurrent squamous cell carcinoma of the vulva. Cancer Treat Rep 64: 639–642

    PubMed  CAS  Google Scholar 

  69. Van Beurden M, tenKate FW, Tjong-A-Hung SP et al. (1998) Human papillomavirus DANN in multicentric vulvar intraepithelial neoplasia. Int J Gynecol Pathol 17: 12–16

    Google Scholar 

  70. Van der Velden J, Lindert ACM van, Gimbrere CHF et al. (1996) Epideiologic data on vulvar cancer: Comparison of hospital with population based data. Gynecol Oncol 62: 379–383

    Article  Google Scholar 

  71. Van der Zee AGJ, deHullu J, Aalders JG et al. (1997) Identification of sentinel node by lymphoscintigraphy in patients with vulvar cancer. Abstract. Int J Gynecol Cancer (Suppl 2) 7: 83

    Google Scholar 

  72. Vilmer C, Cavelier-Balloy B, Nogues C et al. (1998) Analysis of alterations adjacent to invasive vulvar carcinoma and their relationship with the associated carcinoma: a stuy of 67 cases. Eur J Gynecol Oncol 19: 25–31

    CAS  Google Scholar 

  73. Wagenaar HC, Colombo N, Vergote I et al. (2001) Bleomycin, methotrexate and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. Gynecol Oncol 81: 348–354

    Article  PubMed  CAS  Google Scholar 

  74. Weghaupt K (1986) Vulvakarzinom-Elektroresektion und Elektrokoagulation der Vulva (Wiener Methode). In: Zander J, Baltzer J (Hrsg) Erkrankungen der Vulva. Urban & Schwarzenberg, München, S 150–160

  75. Wilkinson EJ (2002) Premalignant and malignant tumors of the vulva. In: Kurman RJ (ed) Blausteins pathology of the female genital tract. Springer, Berlin Heidelberg New York, pp 99–149

  76. Wilkinson EJ (1994) Premalignant and malignant tumors of the vulva. In: Kurman RJ (ed) Blausteins pathology of the female genital tract. Springer, Berlin Heidelberg New York, pp 87–129

  77. Wilkinson EJ, Rico MJ, Pierson KK (1982) Microinvasive carcinoma of the vulva. Int J Gynecol Pathol 1: 29–39

    Article  PubMed  CAS  Google Scholar 

  78. Wittekind C, Meyer HJ, Bootz F (2002) TNM-Klassifikation maligner Tumoren. Springer, Berlin Heidelberg New York

  79. Anders S, Riethdorf L, Löning T (2001) Neoplasien und Präneoplasien des unteren Genitaltrakts. Gynäkologe 34: 590–598

    Article  Google Scholar 

  80. Küppers V (2001) Präneoplasien und Neoplasien der Vulva. In: Bender HG, Diedrich K, Künzel W (Hrsg) Klinik der Frauenheilkunde und Geburtshilfe, Bd. 11 Spezielle gynäkologische Onkologie, 4. Aufl. Urban & Fischer, München Jena

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Frauenklinik des Lukaskrankenhauses, Preussenstraße 84, 41464, Neuss, Deutschland

    H.G. Schnürch

  2. Organkommission Vulva- und Vaginaltumoren, Arbeitsgemeinschaft Gynäkologische Onkologie, Frauenklinik im Kreiskrankenhaus Altötting, Altötting, Deutschland

    P. Hantschmann

Authors
  1. H.G. Schnürch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Hantschmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H.G. Schnürch.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schnürch, H., Hantschmann, P. Vulvakarzinom. Gynäkologe 41, 215–227 (2008). https://doi.org/10.1007/s00129-008-2126-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00129-008-2126-8

Schlüsselwörter

Keywords

Search

Navigation